Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03903731 · ClinicalTrials.gov registry record
Safety and Performance of Journey II BCS Total Knee System Patient Reported Outcome Measures
A clinical trial of Journey II BCS Total Knee System, sponsored by Smith & Nephew.
- Completed
- Registry status
- 600
- Enrollment target
- 5
- Study locations
NCT03903731 is a study of Journey II BCS Total Knee System that has completed, run by Smith & Nephew. The registered enrollment target is 600 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT03903731, a study of Journey II BCS Total Knee System, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
- 5
- Study locations
Study Summary
Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcome Measures.
Conditions Studied
Interventions
- DEVICE Total knee arthroplasty with Journey II BCS Total Knee System
Study Locations (5)
Other
- UZ Leuven - Leuven
- Anglesea Clinic Orthopaedics - Hamilton
Colorado
- Department of Orthopaedics, University of Colorado Denver - Aurora
New York
- Hospital for Special Surgery - New York
Tennessee
- Tennessee Orthopaedic Clinics - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2018-07-19 |
| Est. Completion | 2019-08-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03903731
The ClinicalTrials.gov registry entry for NCT03903731 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Smith & Nephew, which has 72 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Journey II BCS Total Knee System appearing as the primary indexed condition, and to 1 intervention - of which Total knee arthroplasty with Journey II BCS Total Knee System is the first listed.
NCT03903731 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Other, Colorado, New York.
Frequently Asked Questions
What is clinical trial NCT03903731 about?
NCT03903731 is a clinical study titled "Safety and Performance of Journey II BCS Total Knee System Patient Reported Outcome Measures". Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcome Measures.
What is the current status of trial NCT03903731?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2018-07-19. Estimated completion is 2019-08-08.
What conditions does trial NCT03903731 study?
This clinical trial studies the following conditions: Journey II BCS Total Knee System.
What interventions are being tested in trial NCT03903731?
The interventions under investigation include: Total knee arthroplasty with Journey II BCS Total Knee System (DEVICE).
Who is sponsoring clinical trial NCT03903731?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03903731 being conducted?
This trial has 5 study locations across Colorado, New York, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.